{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "ARXS",
  "name": "Arxis, Inc.",
  "url": "https://frontierpicks.com/dossiers/ARXS/",
  "json_url": "https://frontierpicks.com/dossiers/ARXS.json",
  "status": "DORMANT",
  "current_conviction": "MEDIUM",
  "graded_conviction": null,
  "archetype": {
    "code": "a2",
    "n": 2
  },
  "current_thesis": "Arxis’ defense-and-space acquisition story needs another revenue-guidance increase at the next quarterly report to confirm acceleration. The case requires organic growth to hold at the 21% reported on 2026-07-29 and ends first if a weekly close falls below $50.",
  "invalidation_trigger": "A weekly close below $50 ends the re-rating thesis; an unchanged or reduced $1.960–$1.980 billion fiscal 2026 revenue outlook at the next quarterly report separately defeats the operating-acceleration case.",
  "catalyst_date": "2026-09-30",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "space-economy",
    "defense-aerospace",
    "cyclical-industrials"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Dual-class: Class B 340.7M versus Class A 76.8M at the Q2 2026 8-K; Arcline retains voting control and the public float is a minority of shares outstanding.",
    "Listed on Nasdaq 2026-04-17 at $28.00. With under five months of history, 100-day and 200-day moving-average frames do not yet exist for this name.",
    "Guidance and margin figures are non-GAAP. GAAP Q2 2026 was a net loss of $(5)M versus $(29)M a year earlier.",
    "Serial acquirer: five closings between 2026-06-01 and 2026-09-02. Reported growth blends organic and acquired revenue.",
    "Consideration and funding mix for the Schatz Bearing and StratEdge acquisitions were not disclosed in the 2026-09-02 release.",
    "IPO lock-up terms are set in the April 2026 prospectus; a release would enlarge a float that is currently a minority of 430.83M shares outstanding."
  ],
  "body_markdown": "## Current Thesis\n\nArxis’ defense-and-space acquisition story needs another revenue-guidance increase at the next quarterly report; a weekly close below $50 would invalidate the market re-rating thesis first. The operating anchor remains the 2026-07-29 release: second-quarter revenue grew 25%, including 21% organic growth, and management raised its full-year revenue outlook to $1.960–$1.980 billion. [Arxis results](https://ir.arxis.com/news-releases/news-release-details/arxis-reports-second-quarter-2026-results-raises-full-year-2026)\n\nThe acquisition sequence remains intact. Arxis’ announcement is dated 2026-09-03, correcting the announcement date in the previous coverage; StratEdge closed on 2026-09-01 and Schatz Bearing on 2026-09-02. Management expects combined fiscal 2027 revenue exceeding $40 million, but the release gives neither purchase prices nor financing terms. That expectation is company guidance, not realized revenue. [Acquisition announcement](https://ir.arxis.com/news-releases/news-release-details/arxis-completes-acquisitions-schatz-bearing-corporation-and)\n\nAs an interpretation of the dated news and coverage, the narrative is maturing — the company’s investor page reviewed on 2026-09-13 still leads with the September acquisition announcement, while the latest analyst action displayed by StockAnalysis is Citigroup’s 2026-08-13 revision. Neither source establishes renewed participation since the previous note. [Investor relations](https://ir.arxis.com/), [analyst history](https://stockanalysis.com/stocks/arxs/forecast/)\n\n## Bull Case\n\n- **Organic demand supports the acquisition story.** Arxis reported 21% organic revenue growth for the second quarter on 2026-07-29. Acquisitions therefore did not account for all reported growth. [Quarterly release](https://www.sec.gov/Archives/edgar/data/2093536/000119312526323755/arxs-ex99_1.htm)\n- **Cash generation supports further integration.** The 2026-07-29 release reported second-quarter free cash flow of $127 million and quarter-end net leverage of 1.8 times. Those are historical measures, preceding the August and September closings. [Quarterly release](https://www.sec.gov/Archives/edgar/data/2093536/000119312526323755/arxs-ex99_1.htm)\n- **Some acquisition economics are disclosed.** The 2026-08-18 Omnetics announcement valued that transaction at approximately $770 million and stated a combined purchase multiple with MagCanica of approximately 12 times estimated fiscal 2027 adjusted earnings before interest, taxes, depreciation and amortization (EBITDA). The denominator remains management’s forecast. [Filed announcement](https://www.sec.gov/Archives/edgar/data/2093536/000119312526354774/arxs-ex99_1.htm)\n\n## Bear Case\n\n- **Latest acquisition returns remain unmeasurable.** The 2026-09-03 Schatz and StratEdge announcement omitted consideration and funding terms. The disclosed Omnetics–MagCanica multiple cannot establish the economics of these separate transactions. [Acquisition announcement](https://ir.arxis.com/news-releases/news-release-details/arxis-completes-acquisitions-schatz-bearing-corporation-and)\n- **Adjusted profitability exceeds accounting earnings.** On 2026-07-29, Arxis reported second-quarter adjusted EBITDA of $211 million alongside a $5 million net loss under generally accepted accounting principles (GAAP). The adjusted measure does not establish GAAP profitability. [Quarterly release](https://www.sec.gov/Archives/edgar/data/2093536/000119312526323755/arxs-ex99_1.htm)\n- **Acquisitions have expanded equity supply.** Arxis’ 2026-08-18 announcement disclosed issuance of 13,351,964 Class A shares for Omnetics, subject to lockup provisions. This is documented issuance; it does not demonstrate subsequent public-market selling. [Filed announcement](https://www.sec.gov/Archives/edgar/data/2093536/000119312526354774/arxs-ex99_1.htm)\n\n## Setup & Price Structure\n\nThe adjusted daily close was $52.45 on 2026-09-11, with a three-month price increase of 28.0% and a 14-period relative strength index (RSI) of 45.4. The close is below the $53.62 reference close recorded in the 2026-09-05 dossier for 2026-09-04. These supplied observations establish the price comparison; the sample is too small to establish accumulation or a completed base.\n\nThe research boundary remains $50, also RBC Capital’s analyst target dated 2026-07-31. A weekly close below $50 ends the published re-rating case. Its use is an explicit research condition; an analyst target alone does not prove technical support. [RBC action history](https://jp.benzinga.com/quote/ARXS/price-targets)\n\nStockAnalysis’s analyst page reviewed on 2026-09-13 displays an average target of $62 across 11 analysts and a latest revision dated 2026-08-13. That measures published analyst coverage, not ownership or fund flows. No dated moving-average series, short-interest observation or systematic retail-sentiment sample is available here, so crowding cannot be established. [Analyst coverage](https://stockanalysis.com/stocks/arxs/forecast/)\n\n## Catalyst Calendar (next 30 days)\n\n- **2026-09-30 — Fiscal third-quarter end.** The calendar date identified in the 2026-09-05 coverage marks the reporting period containing the August Omnetics closing and September Schatz and StratEdge closings. It is an accounting milestone, not a scheduled results announcement.\n- **~2026-10-28, est. Third-quarter results.** This remains the provisional date identified in the 2026-09-05 coverage, outside the next 30 days. Arxis’ investor page reviewed on 2026-09-13 lists no upcoming event, so the estimate is unconfirmed. The report is the substantive test of organic growth and another guidance increase. [Company event listing](https://ir.arxis.com/)\n\n## What Would Change Our Mind\n\nLoss of the published re-rating boundary would break the price thesis: a weekly close below $50 is the observable condition. Operating confirmation requires the next quarterly report to raise the fiscal 2026 revenue outlook above its 2026-07-29 upper endpoint of $1.980 billion while maintaining organic growth of at least the reported second-quarter rate of 21%. An unchanged or reduced outlook would defeat the narrower acceleration case even if revenue continued growing. [July operating benchmark](https://www.sec.gov/Archives/edgar/data/2093536/000119312526323755/arxs-ex99_1.htm)\n\n## Correlation Notes\n\nArxis remains a single-name acquisition and execution thesis. The 2026-09-03 release identifies Schatz’s exposure to aerospace, defense and space, and StratEdge’s primary exposure to defense and space. Those end markets support the thematic classification; they do not establish a measured relationship with defense shares or space equities. [Acquired-business exposures](https://ir.arxis.com/news-releases/news-release-details/arxis-completes-acquisitions-schatz-bearing-corporation-and)\n\nNo paired return series accompanies the 2026-09-11 price observations. A correlation coefficient or claim that a sector rally will carry Arxis would therefore exceed the evidence.",
  "first_seen": "2026-08-10",
  "last_analyzed": "2026-09-13T12:18:57+00:00",
  "last_synthesized": "2026-09-13",
  "last_update_source": "watchlist_research",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}